A prospective, randomized intra-individual study with the sirolimus coated cypher select(TM) and the paclitaxel(TM) coated express balloon expandable stents for the treatment of patients with two de novo native coronary artery lesions.

Trial Profile

A prospective, randomized intra-individual study with the sirolimus coated cypher select(TM) and the paclitaxel(TM) coated express balloon expandable stents for the treatment of patients with two de novo native coronary artery lesions.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 May 2009

At a glance

  • Drugs Paclitaxel; Sirolimus
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms FRE-RACE
  • Most Recent Events

    • 20 May 2009 Planned number of patients changed from 110 to 112, additional lead trial centre University Hospital Freiburg and lead trial investigator Manfred Zehender as reported by ClinicalTrials.gov.
    • 20 May 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 20 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials. gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top